Institutional Ownership Immuno Gen, Inc. (IMGN)
This table provides information about the institutional ownership of Immuno Gen, Inc. (IMGN). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 1.41 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
721,075
shares
|
$0
0.02% of portfolio
|
Q2 2023
Added 2693.89%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
415,880
shares
|
$0
3.65% of portfolio
|
Q3 2023
New holding
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
150,000
shares
|
$0
0.7% of portfolio
|
Q4 2022
Reduced 88.46%
|
|
|
Kellner Capital, LLC
New York, NY |
Feb 07, 2024 Q4 2023 |
69,200
shares
|
$0
3.7% of portfolio
|
Q4 2023
New holding
|
|
|
Leo Brokerage, LLC
|
Jul 25, 2023 Q2 2023 |
25,000
shares
|
$0
0.05% of portfolio
|
Q1 2023
New holding
|
|
|
Baystate Wealth Management LLC
|
Jan 29, 2024 Q4 2023 |
24,106
shares
|
$0
0.05% of portfolio
|
Q4 2023
New holding
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
50
shares
|
$0
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$0
0.0% of portfolio
|
Q1 2024
Reduced 98.31%
|